Union internationale motonautique
UIM
History
Organigram
President
UIM NATIONAL AUTHORITIES AND OTHER AFFILIATED UIM MEMBERS
What is the UIM
Calendar
Competitions
Standing & Points
Homologations
records
Champions
Cards
Documents
2023 INTERNATIONAL RACING LICENCES
Approved rule changes
Disciplinary sanctions
OFFICIAL FORMS / PROCEDURES
PROPSTARS
Rule Books
Safety
EDUCATION
Youth Development Programme
UIM Environmental Programme
Sustainability
Anti-Doping »
Anti-Doping Regulation
Education
Prohibited List
Therapeutic Use Exemptions (TUE)
UIM Anti-Doping Program
Disciplinary
News & Useful Links
Media
Photo Gallery
Video Gallery
NewsLetter
Press release
UIM Yearbook
Press Clipping
Press Review
Home page
private area
Forgot password ?
Anti-Doping
Therapeutic Use Exemptions
RadEditor - HTML WYSIWYG Editor. MS Word-like content editing experience thanks to a rich set of formatting tools, dropdowns, dialogs, system modules and built-in spell-check.
RadEditor's components - toolbar, content area, modes and modules
Toolbar's wrapper
Content area wrapper
RadEditor hidden textarea
%3cp style%3d%22text-align%3a center%3b margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b%22%3e%3cspan style%3d%22background-color%3a %2365be62%3b color%3a %2365be62%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 20px%3b color%3a %230e2244%3b%22%3e%3cstrong style%3d%22font-size%3a 18px%3b%22%3e%3cspan style%3d%22background-color%3a %230e2244%3b color%3a %2365be62%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 20px%3b color%3a %2365be62%3b%22%3e%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3bTHERAPEUTIC USE EXEMPTIONS%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3chr style%3d%22margin-left%3a 40px%3b%22 /%3e %3cp%3e %3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3e %3c/span%3e%3c/strong%3e%3c/span%3e %3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IS A %3cspan style%3d%22font-size%3a 11pt%3b font-family%3a %27Times New Roman%27%3b color%3a %23474747%3b%22%3e%3c/span%3eTHERAPEUTIC USE EXEMPTION %28TUE%29%3f%26nbsp%3b%3c/span%3e%3c/strong%3e%3cbr /%3e %3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAthletes may have illnesses or conditions that require them to take medications or undergo procedures. %3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eIf the medication or method an athlete is required to use to treat an illness or condition is prohibited as per the World Anti-Doping Agency%26rsquo%3bs %28WADA%29 %3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3eProhibited List%3c/strong%3e%3c/span%3e%3c/a%3e a TUE may give that athlete the authorization to use that substance or method while competing without invoking an anti-doping rule violation %28ADRV%29 and applicable sanction. %3cspan style%3d%22white-space%3a pre%3b%22%3e%3c/span%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eApplications for TUEs are evaluated by a panel of physicians%2c the TUE Committee %28TUEC%29.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 13px%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3ch4 style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3c/h4%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT ARE THE CRITERIA FOR GRANTING A TUE %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAll of the four following criteria must be met %28for more details%2c please refer to the %3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue%22%3eWADA International Standard for Therapeutic Use Exemptions %28ISTUE%29 Article 4.2%3c/a%3e%3c/strong%3e%3c/span%3e%29%3a%3c/span%3e%3c/p%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe athlete has a clear diagnosed medical condition which requires treatment using a prohibited substance or method%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe therapeutic use of the substance will not%2c on the balance of probabilities produce significant enhancement of performance beyond the athlete%26rsquo%3bs normal state of health%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe prohibited substance or method is an indicated treatment for the medical condition%2c and there is no reasonable permitted therapeutic alternative%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe necessity to use that substance or method is not a consequence of the prior use %28without a TUE%29%2c of a substance or method which was prohibited at the time of use.%3c/span%3e%3c/li%3e %3c/ul%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22font-weight%3a bold%3b font-size%3a large%3b font-family%3a %27Segoe UI%27%3b color%3a %2365be62%3b%22%3eWHO SHOULD APPLY FOR A TUE TO THE UIM%2c WHERE AND WHEN %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAthletes who are subject to anti-doping rules would need a TUE to take a prohibited substance or use a prohibited method. You should verify with UIM to know to whom you need to apply and if you can apply %3cspan style%3d%22white-space%3a pre%3b%22%3e %3c/span%3e%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b retroactively.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eFirst%2c check if the required medication or method you intend to take%2c or use is prohibited as per the %3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eWADA Prohibited List.%3c/span%3e%3c/strong%3e%3c/a%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eOr ask your National Anti-Doping Organization %28NADO%29 if it has one %28the list of NADOs is available at%26nbsp%3b%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/code-signatories%23GovernmentFundedOrganizations%22%3ehttps%3a//www.wada-ama.org/en/code-signatories%23GovernmentFundedOrganizations%3c/a%3e%3c/span%3e%3c/strong%3e%29.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eYou have a responsibility to inform your physician%28s%29 that you are an Athlete bound to anti-doping rules. You and your physician%28s%29 should check the %3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3eProhibited List%3c/a%3e%3c/span%3e%3c/strong%3e for the substance/method you are prescribed. If the %26nbsp%3b substance/method is prohibited%2c discuss non-prohibited alternatives%2c if there are none%2c apply for a TUE.%26nbsp%3b Remember Athletes have the ultimate responsibility. Contact your NADO or%26nbsp%3bUIM if you are having difficulties%3c/span%3e.%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eThen%2c %3cspan style%3d%22font-size%3a 17.9999px%3b font-family%3a MyriadPro-Regular%2c Arial%3b color%3a %23003063%3b%22%3e%3c/span%3e%3c/span%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3echeck your status below%2c to determine your competition level and TUE application requirements%3a%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eInternational-Level Athletes %28Pilots/Drivers%29 Definition%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%28a%29 Pilots/Drivers taking part in any competition registered on the UIM International Sporting Calendar%2c which is published at the following link%3a%26nbsp%3b%3ca href%3d%22https%3a//www.uim.sport/CalendarList.aspx%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3ehttps%3a//www.uim.sport/CalendarList.aspx%3c/span%3e%3c/strong%3e%3c/a%3e%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%28b%29 Drivers included in the UIM Registered Testing Pool%2c the UIM Testing Pool or any other Pool established by the UIM.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cstrong%3e%3d%3d%26gt%3b%26nbsp%3b%3c/strong%3e%3c/span%3e%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3eIf it is determined that you are an International-Level Athlete %28Pilots/Drivers%29 %22%3cem%3esee definition here above%22%3c/em%3e%3c/strong%3e%3c/span%3e%26nbsp%3byou must apply to UIM in advance%2c as soon as the need arises%2c unless there are emergency or exceptional circumstances.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eFor substances prohibited in-competition only%2c you should apply for a TUE at least 30 days before your next competition%2c unless one of the exceptions on retroactive TUEs %28see below%29 apply.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3ePlease refer to the section %26ldquo%3b%3cem%3eHow to apply to UIM for a TUE%3c/em%3e%3f%26rdquo%3b below.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eIf you already have a TUE granted by any National Anti-Doping Organization %28NADO%29 for any substaces%2c the UIM may automatically recognize it with the need to review it from the UIM TUEC%2c%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3ePlease refer to the section %22%3cem%3eHow to submit a request for recognition of your Nado%27s TUE to the UIM%3c/em%3e%22%29%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 16px%3b%22%3e%3cstrong%3e%3cspan style%3d%22color%3a %23ff0000%3b%22%3ePlease notify UIM that you have a TUE granted by your NADO%2c even if UIM automatically recognize it %21%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3d%3d%26gt%3b %3cspan style%3d%22text-decoration%3a underline%3b%22%3eIf you are NOT an International-Level Athlete %28Pilots/Drivers%29 and you have been tested by UIM%2c%3c/span%3e%3c/strong%3e%26nbsp%3bthe UIM recognizes a valid TUE granted by your NADO %28%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3eplease refer to the section %22%3c/span%3e%3cem style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 14px%3b text-align%3a justify%3b%22%3eHow to submit a request for recognition of your Nado%27s TUE to the UIM%3c/em%3e%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3e%22%29%26nbsp%3b%3c/span%3e%3c/span%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3eunless you are required to apply for recognition of the TUE because you are competing in an international event.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eIf you are also not a National-Level Athlete as defined by your NADO%2c you must apply for a retroactive TUE after being tested by the UIM.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b%22%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eCAN I GET A RETROACTIVE TUE%3f%3c/span%3e%3c/p%3e %3cdiv style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22color%3a %23c00000%3b font-family%3a %27Segoe UI%27%3b%22%3e%3c/strong%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou may only apply retroactively for a TUE to the UIM%27s TUEC%26nbsp%3bif%3a%3c/span%3e%3c/p%3e %3cul style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 1.1rem%3b padding%3a 0px%3b font-size%3a 14px%3b line-height%3a 1.5%3b list-style-position%3a outside%3b font-family%3a MyriadPro-Regular%2c Arial%3b outline%3a none%3b color%3a %23003063%3b%22%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou required emergency or urgent treatment of a medical condition.%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eThere was insufficient time%2c opportunity or other exceptional circumstances that prevented you from submitting the TUE application%2c or having it evaluated%2c before getting tested.%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou are a lower level driver/pilot who is not under the jurisdiction of the UIM or NADO and were tested.%26nbsp%3b%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou tested positive after using a substance out-of-competition that is only prohibited in-competition %28e.g. glucocorticoids%29.%26nbsp%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cp%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eIn rare and exceptional circumstances and notwithstanding any other provision in the ISTUE%2c%26nbsp%3byou may apply for and be granted retroactive approval for a therapeutic use of a prohibited substance or method%2c if considering the purpose of the Code%2c it would be manifestly unfair not to grant a retroactive TUE.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThis unique retroactive TUE will only be granted with the prior approval of WADA %28and WADA may in its absolute discretion agree with or reject the UIM%27s TUEC%26nbsp%3bdecision%29.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin-top%3a 0px%3b margin-right%3a 0px%3b margin-bottom%3a 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cstrong%3eImportant note%3a%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eUsing a prohibited substance or method without a TUE could result in an Anti-Doping Rule Violation.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eIn case an application for a retroactive TUE is necessary following sample collection%2c you are strongly advised to have a medical file prepared and ready to submit for evaluation.%26nbsp%3b%3c/span%3e%3c/p%3e %3c/div%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eHOW TO APPLY TO THE UIM FOR THE TUE %3f%3c/span%3e%3cstrong style%3d%22color%3a %23c00000%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe UIM encourages TUE applications to be submitted via ADAMS please follow the link here below%2c together with the required medical information. If you do not have an ADAMS account yet%2c contact %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cem%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/em%3e%3c/strong%3e%3c/a%3e%26nbsp%3bto set one up.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/athletes-support-personnel/therapeutic-use-exemptions-tues%22%3ehttps%3a//www.wada-ama.org/en/athletes-support-personnel/therapeutic-use-exemptions-tues%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//adams-help.wada-ama.org/hc/en-us/articles/360018982959-Requesting-a-TUE-Recognition%22%3e%26nbsp%3b%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3eAlternatively%2c download the%26nbsp%3b%3ca target%3d%22_blank%22 href%3d%22/Documents/Editor/documents/Anti-doping/TUE/TUE Application Form as from 2021 - form.pdf%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eUIM%26rsquo%3bs TUE Application Form%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%26nbsp%3band once duly completed and signed%2c send it together with the required medical file to%26nbsp%3b%3ca href%3d%22mailto%3atue@ita.sport%22 style%3d%22box-sizing%3a border-box%3b color%3a %2300b4e1%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3c/span%3e%3c/a%3e%3ca href%3d%22mailto%3aantidoping@uim.sport%22 style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cem%3eantidoping@uim.sport%3c/em%3e%3c/span%3e%3c/strong%3e%3c/a%3e%3c/span%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cem%3e.%3c/em%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYour TUE application must be submitted in legible capital letters or completed electronically.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe medical file must include%3a%3c/span%3e%3c/p%3e %3cul style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-size%3a 14px%3b line-height%3a 1.5%3b list-style-position%3a outside%3b font-family%3a MyriadPro-Regular%2c Arial%3b outline%3a none%3b%22%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eA comprehensive medical history%2c including documentation from the original diagnosing doctor%28s%29 %28where possible%29%3b%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe results of all examinations%2c laboratory investigations and imaging studies relevant to the application.%3c/span%3e%3c/li%3e %3c/ul%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAny costs incurred by the Pilot/Driver in relation to the TUE application and in order to supplement it as required by the TUEC are the responsibility of the Pilot/Driver.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAny TUE application that is not complete or legible will be returned for completion and re-submission.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eTo assist you and your doctor in providing the correct medical documentation%2c we suggest consulting WADA%26rsquo%3bs%26nbsp%3b%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/world-anti-doping-program/guidelines-international-standard-therapeutic-use-exemptions%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eChecklists for TUE applications%3c/span%3e%3c/strong%3e%3c/a%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/search%3ff%255B0%255D%3dfield_resource_collections%253A225%26amp%3bf%255B1%255D%3dfield_resource_versions%25253Afield_resource_version_language%253A91%22%3e%26nbsp%3b%3c/a%3e%3c/span%3e%3c/strong%3efor guidance and support%2c and%26nbsp%3b%3ca href%3d%22https%3a//www.wada-ama.org/en/news/wada-publishes-updated-therapeutic-use-exemption-physician-guidelines-and-checklists%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eMedical Information to Support the Decisions of TUECs%3c/span%3e%3c/strong%3e%3c/a%3e%26nbsp%3bfor guidance on specific common medical conditions%2c treatments%2c substances%2c etc.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eKeep a complete copy of the TUE application form and all medical information submitted in support of your application%2c and proof that it has been sent.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22text-align%3a justify%3b font-weight%3a 700%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eHOW TO SUBMIT A REQUEST FOR RECOGNITION OF YOUR NADO%27S TUE TO THE UIM %3f%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe UIM%27s TUEC may automatically recognise your NADO TUE %28even if it is not insert to ADAMS%29 for purposes of international-level competition with the need to review the relevant clinical information. Nevertheless%2c please inform us when you make an application for a NADO TUE %28that will be not inserted into ADAMS%29.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou can download your TUE certificate directly from ADAMS.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%3cstrong%3eWHAT HAPPENS AT MAJOR EVENTS %3f%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eA Major Event Organization %28MEO%29 requires athletes to apply for the recognition of their TUE if they wish to use a prohibited substance or method in connection with the Event.%3c/span%3e%3c/p%3e %3cp style%3d%22font-size%3a 1.28571rem%3b box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 10pt%3b font-family%3a %27Segoe UI%27%3b%22%3eIf you have a TUE granted by UIM and you will be competing at a Major Event e.g.%2c the Olympic Games%2c you should contact the MEO for information on their recognition process%3c/span%3e%3c/p%3e %3cdiv%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cbr /%3e %3c/span%3e%3c/div%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHEN WILL I RECEIVE A DECISION ON MY TUE APPLICATION %28OR REQUEST FOR RECOGNITION%29 %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eThe UIM%26rsquo%3bs TUEC%26rsquo%3bs decision will be communicated in writing to you within 21 days from the date of receipt of the complete TUE application %5bor request for recognition%5d%2c including the required medical information.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b%22%3e%3cstrong%3e%3cspan style%3d%22color%3a %2365be62%3b%22%3eWHAT IF I NEED TO RENEW MY TUE%26nbsp%3b%3f%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eEach TUE has a specific duration%2c at the end of which it expires automatically. Should you need to continue to use the prohibited substance or method%2c it is your responsibility to submit a new application for a TUE with updated medical information ahead of the expiry date%2c so that there is sufficient time for a decision to be made prior to the expiry of the current TUE.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3eImportant note%3a%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe presence %28following sample collection%29%2c use%2c possession or administration of the prohibited substance or method must be consistent with the terms of your TUE. Therefore%2c if you require a materially different dosage%2c frequency%2c%26nbsp%3brouteor duration of administration%2c you should contact us%2c as%26nbsp%3byou may be required to apply for a new TUE. Some substances and dosages%2c e.g. insulin%2c are often modified during treatment and these possible fluctuations should be mentioned by the treating doctor in the TUE application and are typically accepted by the UIM%27s TUEC.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b color%3a %230e2244%3b%22%3e%3cem%3e%26nbsp%3b%3c/em%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IF MY UIM%27S TUE APPLICATION IS DENIED %3f%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eA decision to deny a TUE application will include a written explanation of the reason%28s%29 for the denial. If it is not clear to you%2c please contact us to understand exactly why the TUE was denied. Sometimes%2c there may be a critical piece of information%2c diagnostic test%2c laboratory results%2c etc. missing. In which case%2c you should resubmit your application.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou and/or your NADO may refer the matter to WADA for review no later than 21 days after notification of the UIM%27s TUEC decision. You should send the same information that you submitted to us%2c and on which the decision to deny the TUE was based%2c via a secure online method or by registered post to%3a%3c/span%3e%3c/p%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eWADA Medical Department%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e World Anti-Doping Agency%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eStock Exchange Tower%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3e800 Place Victoria %28Suite 1700%29%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eP.O. Box 120%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eMontreal %28Quebec%29 H4Z 1B7%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eCanada%3c/address%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe email address to enquire and/or send the request for review is%3a%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%26nbsp%3b%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3em%3c/a%3e%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3eedical@wada-ama.org%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3ePlease note that WADA is not obliged to proceed with a request for a review. In that case%2c you and/or your NADO may appeal to the Court of Arbitration for Sport %28CAS%29.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IF MY NADO%27S TUE IS NOT RECOGNIZED BY THE UIM %3f%26nbsp%3b%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou and/or your NADO have 21 days from the date of decision to refer the matter to WADA for review. The email address to enquire and/or send the request for review is%3a%26nbsp%3b%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3emedical@wada-ama.org%3c/span%3e%3c/strong%3e%3c/a%3e. %3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAlternatively%2c you may send it to%3a%26nbsp%3b%3c/span%3e%3c/p%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eWADA Medical Department%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e World Anti-Doping Agency%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e Stock Exchange Tower%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3e800 Place Victoria %28Suite 1700%29%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eP.O. Box 120%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eMontreal %28Quebec%29 H4Z 1B7%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eCanada%3c/address%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe same information that was provided to your NADO should be submitted to WADA. Please use a secure online method unless sending by registered post.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3ePending WADA%26rsquo%3bs decision%2c your NADO%3c/span%3e%26nbsp%3bTUE remains valid for national-level%26nbsp%3bcompetition%26nbsp%3band out-of-competition testing only.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eIf the matter is not referred to WADA for review%2c your NADO must determine whether the original TUE that was granted should remain valid for national-level competition%26nbsp%3band out-of-competition testing.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22text-align%3a center%3b%22%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWILL MY MEDICAL INFORMATION BE TREATED IN A CONFIDENTIAL MANNER %3f%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAll the information contained in a TUE application%2c including the supporting medical information and any other information related to the evaluation of your TUE request is kept strictly confidential and treated in accordance with the Athlete%26rsquo%3bs Declaration contained in the ADAMS TUE and in the TUE application form which can be found%26nbsp%3b%3ca href%3d%22/Documents/Editor/documents/Anti-doping/TUE/TUE Application Form as from 2021 - form.pdf%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3ehere%3c/span%3e%3c/strong%3e%3c/a%3e. All members of the TUEC and any other authorised recipients of your TUE request and related information %28as described in the Athlete%26rsquo%3bs Declaration%29 are subject to a professional or contractual confidentiality obligation.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3ePlease review the terms of the Athlete%26rsquo%3bs Declaration carefully. In particular%2c note that should you wish to revoke the right of the UIM%27s TUEC to obtain the information related to your TUE in accordance with the Athlete%26rsquo%3bs Declaration%2c your TUE application will be deemed withdrawn without approval %28or recognition%29 being granted.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eInformation related to your TUE request will be retained by the UIM%27s TUEC and any other authorised recipients for no longer than necessary for the purposes stated in the Athlete%26rsquo%3bs Declaration%2c in accordance with the International Standard for the Protection of Privacy and Personal Information.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 13px%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eCONTACT INFORMATION%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eFor any further information and questions in relation to UIM%26rsquo%3bs personal information practices%2c please contact the UIM Anti-Doping Administrator at %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/strong%3e%3c/a%3e.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e If you have a doubt as regards to which organization you should apply for a TUE%2c or as to the recognition process%2c or any other question with regard to TUEs%2c please contact the UIM Anti-Doping Administrator at %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/strong%3e%3c/a%3e.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eOTHER USEFUL LINKS%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3ca target%3d%22_blank%22 href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3eWADA International Standard for Therapeutic Use Exemptions %28ISTUE%29%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/contact-us%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%26nbsp%3b%3c/a%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/contact-us%22%3eWADA Contact form%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption/checklist-therapeutic-use-exemption-tue-application-general%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3eWADA Checklists for TUE Applications%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3ca href%3d%22https%3a//adel.wada-ama.org/%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3eWADA Anti-Doping Education and Learning %28ADEL%29%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%3c/p%3e
RadEditor's bottom area: Design, Html and Preview modes, Statistics module and resize handle.
It contains RadEditor's Modes/views (HTML, Design and Preview), Statistics and Resizer
Editor Mode buttons
Statistics module
Editor resizer
Preview
RadEditor - please enable JavaScript to use the rich text editor.
RadEditor's Modules - special tools used to provide extra information such as Tag Inspector, Real Time HTML Viewer, Tag Properties and other.
Log book